4//SEC Filing
Daniels Mark 4
Accession 0001214659-21-003703
CIK 0001581280other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:30 PM ET
Size
8.9 KB
Accession
0001214659-21-003703
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Sale
Common Stock
2021-03-29$114.39/sh−377$43,125→ 66,926 total - Exercise/Conversion
Common Stock
2021-03-29$8.82/sh+377$3,325→ 67,303 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-29−377→ 2,261 totalExercise: $8.82Exp: 2027-09-28→ Common Stock (377 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001753840
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 4:30 PM ET
- Size
- 8.9 KB